Learn how drug absorption and predictive modeling drive advancements in pharmaceuticals and precision medicine.
Harrow prices $60M offering one day after acquiring US, Canadian rights to new dry eye treatment
Eye biotech Harrow Health is looking to raise $60 million after buying the rights to an eye product newly approved by the FDA. The company